These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Berberine inhibits hepatitis C virus entry by targeting the viral E2 glycoprotein. Hung TC; Jassey A; Liu CH; Lin CJ; Lin CC; Wong SH; Wang JY; Yen MH; Lin LT Phytomedicine; 2019 Feb; 53():62-69. PubMed ID: 30668413 [TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives. Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors. Xiao S; Wang Q; Si L; Zhou X; Zhang Y; Zhang L; Zhou D Eur J Med Chem; 2016 Nov; 124():1-9. PubMed ID: 27565552 [TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein E peptides inhibit hepatitis C virus entry by blocking virus binding. Liu S; McCormick KD; Zhao W; Zhao T; Fan D; Wang T Hepatology; 2012 Aug; 56(2):484-91. PubMed ID: 22334503 [TBL] [Abstract][Full Text] [Related]
9. A novel small molecule inhibitor of hepatitis C virus entry. Baldick CJ; Wichroski MJ; Pendri A; Walsh AW; Fang J; Mazzucco CE; Pokornowski KA; Rose RE; Eggers BJ; Hsu M; Zhai W; Zhai G; Gerritz SW; Poss MA; Meanwell NA; Cockett MI; Tenney DJ PLoS Pathog; 2010 Sep; 6(9):e1001086. PubMed ID: 20838466 [TBL] [Abstract][Full Text] [Related]
10. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process. Lv XQ; Zou LL; Tan JL; Li H; Li JR; Liu NN; Dong B; Song DQ; Peng ZG Eur J Pharmacol; 2020 Sep; 883():173323. PubMed ID: 32622669 [TBL] [Abstract][Full Text] [Related]
11. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway. Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784 [TBL] [Abstract][Full Text] [Related]
12. Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors. Yu F; Peng Y; Wang Q; Shi Y; Si L; Wang H; Zheng Y; Lee E; Xiao S; Yu M; Li Y; Zhang C; Tang H; Wang C; Zhang L; Zhou D Eur J Med Chem; 2014 Apr; 77():258-68. PubMed ID: 24650713 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and Anti-HCV Activities of 18β-Glycyrrhetinic Acid Derivatives and Their In-Silico ADMET Analysis. Zhang KX; Wang PR; Chen F; Qian XJ; Jia L; Liu XJ; Li L; Jin YS Curr Comput Aided Drug Des; 2021; 17(6):831-837. PubMed ID: 32860363 [TBL] [Abstract][Full Text] [Related]
14. Identification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C Virus. Vausselin T; Séron K; Lavie M; Mesalam AA; Lemasson M; Belouzard S; Fénéant L; Danneels A; Rouillé Y; Cocquerel L; Foquet L; Rosenberg AR; Wychowski C; Meuleman P; Melnyk P; Dubuisson J J Virol; 2016 Oct; 90(19):8422-34. PubMed ID: 27412600 [TBL] [Abstract][Full Text] [Related]
16. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection. Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233 [TBL] [Abstract][Full Text] [Related]
17. Novel small-molecule inhibitors of hepatitis C virus entry block viral spread and promote viral clearance in cell culture. Coburn GA; Fisch DN; Moorji SM; de Muys JM; Murga JD; Paul D; Provoncha KP; Rotshteyn Y; Han AQ; Qian D; Maddon PJ; Olson WC PLoS One; 2012; 7(4):e35351. PubMed ID: 22545104 [TBL] [Abstract][Full Text] [Related]
18. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro. Hang X; Peng H; Song H; Qi Z; Miao X; Xu W J Virol Methods; 2015 Sep; 222():150-7. PubMed ID: 26116793 [TBL] [Abstract][Full Text] [Related]
19. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry. Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204 [TBL] [Abstract][Full Text] [Related]